Invus Public Equities, L.P. - Insider Trading & Ownership

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Invus Public Equities, L.P.
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2026-02-02
Purchase
2026-02-04
4:25 pm
LEXICON PHARMACEUTICALS INC.LXRXInvus Global Management LLC
Siren L.L.C.
DEBBANE RAYMOND
Artal Participations S.a r.l.
Artal International S.C.A.
Artal International Management S.A.
Artal Group S.A.
Westend S.A.
Stichting Administratiekantoor Westend
Director
10% Owner
1,538,462$1.3$2,000,00142,606,727
(Indirect)
View
2024-12-10
Sale
2024-12-12
4:39 pm
Scholar Rock Holding CorpSRRKInvus Public Equities L.P.
Invus Public Equities Advisors LLC
Siren L.L.C.
Invus Global Management LLC
DEBBANE RAYMOND
10% Owner
1,600,000$41.65$66,640,0009,250,005
(Direct)
View
2024-11-25
Sale
2024-11-27
4:31 pm
Scholar Rock Holding CorpSRRKInvus Public Equities L.P.
Invus Public Equities Advisors LLC
Siren L.L.C.
Invus Global Management LLC
DEBBANE RAYMOND
10% Owner
409,433$38.49$15,757,63910,850,005
(Direct)
View
2024-08-07
Sale
2024-08-09
4:30 pm
GLYCOMIMETICS INCGLYCInvus Public Equities L.P.
Invus Public Equities Advisors LLC
Siren L.L.C.
Invus Global Management LLC
DEBBANE RAYMOND
10% Owner
322,361$0.18987$61,2066,317,565
(Direct)
View
2024-08-05
Sale
2024-08-07
4:30 pm
GLYCOMIMETICS INCGLYCInvus Public Equities L.P.
Invus Public Equities Advisors LLC
Siren L.L.C.
Invus Global Management LLC
DEBBANE RAYMOND
10% Owner
220,255$0.18698$41,1846,639,926
(Direct)
View
2024-08-01
Sale
2024-08-05
4:53 pm
GLYCOMIMETICS INCGLYCInvus Public Equities L.P.
Invus Public Equities Advisors LLC
Siren L.L.C.
Invus Global Management LLC
DEBBANE RAYMOND
10% Owner
349,764$0.20327$71,0976,860,181
(Direct)
View
2024-07-26
Sale
2024-07-30
5:16 pm
GLYCOMIMETICS INCGLYCInvus Public Equities L.P.
Invus Public Equities Advisors LLC
Siren L.L.C.
Invus Global Management LLC
DEBBANE RAYMOND
10% Owner
1,379,119$0.2286$315,2627,209,945
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2025-12-11
Exercise
2026-02-06
5:35 pm
N/A
N/A
Scholar Rock Holding CorpSRRKInvus Global Management LLC
Siren L.L.C.
DEBBANE RAYMOND
10% Owner
1,575,008$7.3510,825,013
(Direct)
View
2025-12-11
Exercise
2026-02-06
5:35 pm
2022-06-22
2025-12-31
Scholar Rock Holding CorpSRRKInvus Global Management LLC
Siren L.L.C.
DEBBANE RAYMOND
10% Owner
1,575,008$010,825,013
(Direct)
View
2026-02-02
Option Award
2026-02-04
4:25 pm
N/A
N/A
LEXICON PHARMACEUTICALS INC.LXRXInvus Global Management LLC
Siren L.L.C.
DEBBANE RAYMOND
Artal Participations S.a r.l.
Artal International S.C.A.
Artal International Management S.A.
Artal Group S.A.
Westend S.A.
Stichting Administratiekantoor Westend
Director
10% Owner
22,400,000$1.342,606,727
(Indirect)
View
2026-02-02
Option Award
2026-02-04
4:25 pm
N/A
N/A
LEXICON PHARMACEUTICALS INC.LXRXInvus Global Management LLC
Siren L.L.C.
DEBBANE RAYMOND
Artal Participations S.a r.l.
Artal International S.C.A.
Artal International Management S.A.
Artal Group S.A.
Westend S.A.
Stichting Administratiekantoor Westend
Director
10% Owner
367,145$6542,606,727
(Indirect)
View

Ownership
2024-07-29
6:03 pm
N/A
N/A
Scholar Rock Holding CorpSRRKSiren L.L.C.
Invus Global Management LLC
DEBBANE RAYMOND
10% Owner
0$012,834,446
(Direct)
View

Ownership
2024-07-29
5:55 pm
N/A
N/A
GLYCOMIMETICS INCGLYCSiren L.L.C.
Invus Global Management LLC
DEBBANE RAYMOND
10% Owner
0$08,589,064
(Direct)
View

Ownership
2024-07-29
5:31 pm
N/A
N/A
LEXICON PHARMACEUTICALS INC.LXRXSiren L.L.C.
Invus Global Management LLC
Director
10% Owner
0$038,918,903
(Indirect)
View